Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Gilz-Activin A as a novel signaling axis orchestrating mesenchymal stem cell and Th17 cell interplay

Luz-Crawford, Patricia, Espinosa-Carrasco, Gabriel, Ipseiz, Natacha, Contreras, Rafael, Tejedor, Gautier, Medina, Daniel A., Vega-Letter, Ana-Maria, Ngo, Devi, Morand, Eric F., Pène, Jérôme, Hernandez, Javier, Jorgensen, Christian and Djouad, Farida 2018. Gilz-Activin A as a novel signaling axis orchestrating mesenchymal stem cell and Th17 cell interplay. Theranostics 8 (3) , pp. 846-859. 10.7150/thno.21793

PDF - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (2MB) | Preview


Mesenchymal stem cells (MSC) are highly immunosuppressive cells able to reduce chronic inflammation through the active release of mediators. Recently, we showed that glucocorticoid-induced leucine zipper (Gilz) expression by MSC is involved in their therapeutic effect by promoting the generation of regulatory T cells. However, the mechanisms underlying this pivotal role of Gilz remain elusive. Methods and Results In this study, we have uncovered evidence that Gilz modulates the phenotype and function of Th1 and Th17 cells likely by upregulating the level of Activin A and NO2 secreted by MSC. Adoptive transfer experiments sustained this Gilz-dependent suppressive effect of MSC on Th1 and Th17 cell functions. In immunoregulatory MSC, obtained by priming with IFN-γ and TNF-α, Gilz was translocated to the nucleus and bound to the promoters of inos and Activin βA to induce their expression. The increased expression of Activin A directly impacted on Th17 cells fate by repressing their differentiation program through the activation of Smad3/2 and enhancing IL-10 production. Conclusion Our results reveal how Gilz controls inos and Activin βA gene expression to ultimately assign immunoregulatory status to MSC able to repress the pathogenic Th17 cell differentiation program and uncover Activin A as a novel mediator of MSC in this process.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Ivyspring International Publisher
ISSN: 1838-7640
Date of First Compliant Deposit: 26 January 2018
Date of Acceptance: 9 November 2017
Last Modified: 15 Dec 2019 12:58

Citation Data

Cited 2 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics